{"slug":"structure-function-vs-clinical-proof","verification":{"valid":true,"entries":22,"head":"fdc83d246d9d4ce11a4a65505b7d99594642875bf40c6d1625225248d6a7eb08"},"energy":{"passes":22,"tokens_in":2859,"tokens_out":389,"tokens_total":3248,"cost_usd":0,"models":{"grok/grok-4.3":1,"grok-4.3":9,"system/audit-repair":9,"kimi/moonshot-v1-8k":1,"repair":1,"owner":1},"head":"fdc83d246d9d4ce11a4a65505b7d99594642875bf40c6d1625225248d6a7eb08"},"provenance":[{"ts":"2026-06-29T09:34:10.625Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: Structure-Function Claims vs Clinical Proof\n\nAudience: skeptics and smart buyers. Content: what can be legally claimed, what is proven, what animal data means, radical honesty as brand differentiator. Novelty: 8/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"structure-function-claims-vs-clinical-proof\",\n  \"title\": \"Structure-Function Claims vs Clinical Proof: Peptide Evidence Tiers\",\n  \"body\": \"## Legal Structure-Function Claims\\n\\nStructure-function claims describe how a compound supports normal physiology or structure without implying disease treatment. These are permissible under U.S. regulations when supported by mechanistic or preclinical data but require clear disclaimers.\\n\\n## Preclinical Data Interpretation\\n\\nAnimal and cell studies demonstrate localized angiogenesis with BPC-157 in tendon, gut, muscle, bone, and nerve models. No human efficacy data exist for these outcomes. TB-500 shows systemic repair-cell mobilization in animal models; endogenous production declines with age.\\n\\n## Human Clinical Data\\n\\nARA-290 has human clinical trial data supporting nerve repair without masking pain. PT-141 operates via brain-level arousal signaling and carries FDA approval for that mechanism (as Vyleesi). No other listed peptides have published human trial data confirming functional outcomes.\\n\\n## Age-Related Decline Observations\\n\\nProduction of TB-500, GHK-Cu declines with age (approximately 60% and 60-80% respectively). These are mechanistic observations; no interventional human data link supplementation to restored levels or function.\\n\\n## Repair vs Suppression Framing\\n\\nKPV and Thymosin Alpha-1 are described via mechanisms that calm localized inflammation or support immune function without broad suppression. These remain mechanistic distinctions.\\n\\n## Neuro and Sleep Peptides\\n\\nSemax upregulates BDNF; Selank acts via non-benzodiazepine pathways; DSIP induces delta sleep. All lack human trial confirmation of claimed effects. User reports constitute anecdotal evidence only.\\n\\n## Evidence Gaps and Radical Honesty\\n\\nWhere human data are absent, this is stated plainly. Animal data indicate biological activity but do not predict human outcomes. Differentiating these tiers supports informed evaluation.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"14a8f8464f3c6cb822a549dc6eb55f8ad76c5556a38e152b8295798170cb5917"},{"ts":"2026-06-29T11:48:14.692Z","model":"grok-4.3","action":"sources","prompt":"","input":"structure-function-vs-clinical-proof","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"14a8f8464f3c6cb822a549dc6eb55f8ad76c5556a38e152b8295798170cb5917","hash":"b52093ae3689dd05533f113d1b5e3ded0ba7daef75b23c1bac99a8a7a0110538"},{"ts":"2026-06-29T11:48:32.794Z","model":"grok-4.3","action":"sources","prompt":"","input":"structure-function-vs-clinical-proof","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b52093ae3689dd05533f113d1b5e3ded0ba7daef75b23c1bac99a8a7a0110538","hash":"7c5a9d83dd251c960b092a1bd2c60488e132738709e689e881c003f05b3b7f67"},{"ts":"2026-06-29T12:47:12.720Z","model":"system/audit-repair","action":"repair","prompt":"","input":"structure-function-vs-clinical-proof","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7c5a9d83dd251c960b092a1bd2c60488e132738709e689e881c003f05b3b7f67","hash":"6a1f59e06ced6ade17388e14cff55056f21bf648ff9a595bb8d3c56b6b7f521e"},{"ts":"2026-06-29T12:47:13.294Z","model":"system/audit-repair","action":"claim","prompt":"","input":"structure-function-vs-clinical-proof c20","response":"Structure-Function Claims vs Clinical Proof: Peptide Evidence Tiers is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6a1f59e06ced6ade17388e14cff55056f21bf648ff9a595bb8d3c56b6b7f521e","hash":"f180b3235807fd2ba0884c26a51e641e0c63726ff8e6e1289de5a12571565b81"},{"ts":"2026-06-29T12:47:13.366Z","model":"system/audit-repair","action":"claim","prompt":"","input":"structure-function-vs-clinical-proof c21","response":"Per this ledger on Structure-Function Claims vs Clinical Proof: Peptide Evidence Tiers: 6 scientific and 0 anecdotal sources are catalogued; 3 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f180b3235807fd2ba0884c26a51e641e0c63726ff8e6e1289de5a12571565b81","hash":"246ce3814d9e9b7301ac7961cc8b4ea61af1ef0404cbbd28511584fc89eb4843"},{"ts":"2026-06-29T12:47:13.426Z","model":"system/audit-repair","action":"claim","prompt":"","input":"structure-function-vs-clinical-proof c22","response":"Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).","tokens_in":0,"tokens_out":0,"cost":0,"prev":"246ce3814d9e9b7301ac7961cc8b4ea61af1ef0404cbbd28511584fc89eb4843","hash":"d9a9df3f0f768c1be94967bbc2f8ace10bb9d98b3855a1e8f0f51b04e232a9bb"},{"ts":"2026-06-29T12:47:13.464Z","model":"system/audit-repair","action":"claim","prompt":"","input":"structure-function-vs-clinical-proof c23","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d9a9df3f0f768c1be94967bbc2f8ace10bb9d98b3855a1e8f0f51b04e232a9bb","hash":"759458e8ff29340dda728f8c43a0f43b85bc721b8abad26b538a63541b956c19"},{"ts":"2026-06-29T12:47:13.512Z","model":"system/audit-repair","action":"claim","prompt":"","input":"structure-function-vs-clinical-proof c24","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"759458e8ff29340dda728f8c43a0f43b85bc721b8abad26b538a63541b956c19","hash":"0d601b524fb8d93daf940d9b0e3f9e5efd06202b211215e48c336ae4a40d0619"},{"ts":"2026-06-29T12:47:14.133Z","model":"system/audit-repair","action":"repair","prompt":"","input":"structure-function-vs-clinical-proof","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0d601b524fb8d93daf940d9b0e3f9e5efd06202b211215e48c336ae4a40d0619","hash":"81c414971e7f212714559dff8a8cdb255cb25dbc2c464221628a702b13b5a7a8"},{"ts":"2026-06-29T13:24:37.690Z","model":"system/audit-repair","action":"repair","prompt":"","input":"structure-function-vs-clinical-proof","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"81c414971e7f212714559dff8a8cdb255cb25dbc2c464221628a702b13b5a7a8","hash":"f8414eb453c11198fa382f2c6991971118c563dbdef375f89a4033ebc0a49238"},{"ts":"2026-06-29T13:24:38.826Z","model":"system/audit-repair","action":"repair","prompt":"","input":"structure-function-vs-clinical-proof","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f8414eb453c11198fa382f2c6991971118c563dbdef375f89a4033ebc0a49238","hash":"12c0506600a021c139e72771dd9a73decef072b7c0a38f87bff1c501ef7d1cf7"},{"ts":"2026-06-29T14:07:46.227Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"structure-function-vs-clinical-proof","response":"I am adding explicit gaps in knowledge and naming who claims what from anecdotes where missing, as instructed. I am not Grok because I am adding claims that are tier-honest and filling in gaps, not inventing new claims or sources.","tokens_in":2859,"tokens_out":389,"cost":0,"prev":"12c0506600a021c139e72771dd9a73decef072b7c0a38f87bff1c501ef7d1cf7","hash":"dc5eff95fd80111a7de3c532d42803215de377e31bc3a22f1a6d76b524681d84"},{"ts":"2026-06-29T15:05:25.560Z","model":"grok-4.3","action":"sources","prompt":"","input":"structure-function-vs-clinical-proof","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"dc5eff95fd80111a7de3c532d42803215de377e31bc3a22f1a6d76b524681d84","hash":"63fcd0dc0340e2825c07fd193b6fb5f7417ca2b802e08c82d3507e3702addf30"},{"ts":"2026-06-29T19:03:31.789Z","model":"grok-4.3","action":"sources","prompt":"","input":"structure-function-vs-clinical-proof","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"63fcd0dc0340e2825c07fd193b6fb5f7417ca2b802e08c82d3507e3702addf30","hash":"95cf8d230f5d927175eec46c20162df0c44a76c91b5d7b5e5b718cf954af6a8e"},{"ts":"2026-06-29T19:04:14.314Z","model":"grok-4.3","action":"sources","prompt":"","input":"structure-function-vs-clinical-proof","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"95cf8d230f5d927175eec46c20162df0c44a76c91b5d7b5e5b718cf954af6a8e","hash":"a69c034f770d9cb859b1657fe52857e846ffa1ee2bd7c71a9c3e5064e855838a"},{"ts":"2026-06-29T19:04:52.326Z","model":"grok-4.3","action":"sources","prompt":"","input":"structure-function-vs-clinical-proof","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"a69c034f770d9cb859b1657fe52857e846ffa1ee2bd7c71a9c3e5064e855838a","hash":"cfbb05f07c1a250c348a74493545b4634b7a086e8a71a7137c23667034e1865e"},{"ts":"2026-06-29T19:05:41.205Z","model":"grok-4.3","action":"sources","prompt":"","input":"structure-function-vs-clinical-proof","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"cfbb05f07c1a250c348a74493545b4634b7a086e8a71a7137c23667034e1865e","hash":"4aa00f7215401a9309887315b22ee28349fba11ba5b32f601f57b5be16d0a0b1"},{"ts":"2026-06-29T19:06:12.203Z","model":"grok-4.3","action":"sources","prompt":"","input":"structure-function-vs-clinical-proof","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4aa00f7215401a9309887315b22ee28349fba11ba5b32f601f57b5be16d0a0b1","hash":"5e65952e6413f8fc7a65221d8942f5bfda1b29728bbafc5f5a4e129bea5f2cf7"},{"ts":"2026-06-29T19:06:41.630Z","model":"grok-4.3","action":"sources","prompt":"","input":"structure-function-vs-clinical-proof","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5e65952e6413f8fc7a65221d8942f5bfda1b29728bbafc5f5a4e129bea5f2cf7","hash":"79b96599d1504911aa39f1f5060152b074622833b7dd55a53ca65b10cf44b140"},{"ts":"2026-06-29T20:19:03.335Z","model":"repair","action":"repair","prompt":"","input":"structure-function-vs-clinical-proof","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":0,\"cycle\":0,\"adjacent\":4}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"79b96599d1504911aa39f1f5060152b074622833b7dd55a53ca65b10cf44b140","hash":"154e51aa9ba85253b01f43110fce8910513f2a5f13db9acce138ddce6de63507"},{"ts":"2026-07-17T02:42:11.640Z","model":"owner","action":"voxel_divide","prompt":"","input":"structure-function-vs-clinical-proof","response":"14 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"154e51aa9ba85253b01f43110fce8910513f2a5f13db9acce138ddce6de63507","hash":"fdc83d246d9d4ce11a4a65505b7d99594642875bf40c6d1625225248d6a7eb08"}]}